Exploring Emergency Use Authorizations, Operation Warp Speed, the Case of Mifepristone, and the Dynamics of Agency Decision-Making

This chapter delves into the complex web of decisions and actions surrounding Emergency Use Authorizations (E.U.A.s), the rapid development of Operation Warp Speed, and regulating drugs such as Mifepristone. Throughout each section, I navigate the challenges, complexities, and implications of unprecedented measures in contemporary healthcare and policy. Case-specific examples highlight the delicate balance between the urgency to provide access to crucial medical interventions and the imperative to maintain public trust in the decision-making processes of regulatory agencies.